Professor of Pediatrics and Neurology, Ohio State University
Neurology
Dr. Jerry R. Mendell, MD
|
|
Give Review
Dr. Jerry R. Mendell is an expert in the field of Neurology. He attended University of Texas Southwestern Medical School. He received awards:"America's Top Doctors". Doctor Jerry R. Mendell, MD is a published doctor and has 91 publications published. The lastest was: 'AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models.'
Publications
- Outcome reliability in non-Ambulatory Boys/Men with Duchenne muscular dystrophy.
- Perspectives on best practices for gene therapy programs.
- A slowly progressive form of limb-girdle Muscular dystrophy type 2C associated with founder mutation in the SGCG gene in Puerto Rican Hispanics.
- AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models.
- Reliability and validity of ACTIVE-seated: An outcome in dystrophinopathy.
- Visual Diagnosis: Chest Pain in a Boy With Duchenne Muscular Dystrophy and Cardiomyopathy.
- Gene Therapy for Muscular Dystrophy: Moving the Field Forward.
- Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA - a dose response study in mice and nonhuman primates.
- A Phase I/IIa Follistatin Gene Therapy Trial for Becker Muscular Dystrophy.
- Charting a Clear Path: The ASGCT Standardized Pathways Conference.
- One Year Outcome of Boys With Duchenne Muscular Dystrophy Using the Bayley-III Scales of Infant and Toddler Development.
- VIP Expressing Dendritic Cells Protect Against Spontaneous Autoimmune Peripheral Polyneuropathy.
- Dexmedetomidine and ketamine sedation for muscle biopsies in patients with Duchenne muscular dystrophy.
- The 2-min walk test is sufficient for evaluating walking abilities in sporadic inclusion body myositis.
- AAV1.NT-3 gene therapy for Charcot-Marie-Tooth Neuropathy.
- Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin α2 surrogates.
- Anti-dystrophin T cell responses in Duchenne muscular dystrophy: prevalence and a glucocorticoid treatment effect.
- Eteplirsen for the treatment of Duchenne muscular dystrophy.
- Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network.
- Obituary: m. Richard koenigsberger: lifetime contributions to child neurology.
- Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene.
- Impaired regeneration in LGMD2A supported by increased PAX7-positive satellite cell content and muscle-specific microrna dysregulation.
- Correlation of knee strength to functional outcomes in becker Muscular dystrophy.
- Proof of concept of the ability of the kinect to quantify upper extremity function in dystrophinopathy.
- Precordial R Wave Height Does Not Correlate with Echocardiographic Findings in Boys with Duchenne Muscular Dystrophy.
- Update on the treatment of Duchenne muscular dystrophy.
- Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy.
- Translating the genomics revolution: the need for an international gene therapy consortium for monogenic Diseases.
- AAV-mediated Overexpression of Human ?7 Integrin Leads to Histological and Functional Improvement in Dystrophic Mice.
- LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy.
- Cardiac management in neuroMuscular diseases.
- RNA Interference Inhibits DUX4-induced Muscle Toxicity In Vivo: Implications for a Targeted FSHD Therapy.
- Homologous Recombination Mediates Functional Recovery of Dysferlin Deficiency following AAV5 Gene Transfer.
- Emerging drugs for Duchenne muscular dystrophy.
- Maternal uniparental disomy of chromosome 4 in a patient with limb-girdle Muscular dystrophy 2E confirmed by SNP array technology.
- Gene Therapy for Muscular Dystrophy: Lessons Learned and Path Forward.
- Effects of Angiotensin-Converting Enzyme Inhibitors and/or Beta Blockers on the Cardiomyopathy in Duchenne Muscular Dystrophy.
- Evidence-based path to newborn screening for Duchenne muscular dystrophy.
- Knee extensor strength exhibits potential to predict function in sporadic inclusion-body myositis.
- Astrocytes from familial and sporadic ALS patients are toxic to motor neurons.
- Cardiovascular magnetic resonance of cardiomyopathy in limb girdle Muscular dystrophy 2B and 2I.
- Systemic Gene Delivery in Large Species for Targeting Spinal Cord, Brain, and Peripheral Tissues for Pediatric Disorders.
- Novel and recurrent EMD mutations in patients with Emery-Dreifuss Muscular dystrophy, identify exon 2 as a mutation hot spot.
- The Muscular dystrophies: distinct pathogenic mechanisms invite novel therapeutic approaches.
- Novel LMNA mutations in patients with Emery-Dreifuss Muscular dystrophy and functional characterization of four LMNA mutations.
- Peptide-based inhibition of NF-κB rescues diaphragm muscle contractile dysfunction in a murine model of Duchenne muscular dystrophy.
- AAV-mediated gene therapy to the isolated limb in rhesus macaques.
- Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle Muscular dystrophy, type 2D.
- Dystrophin immunity in Duchenne's muscular dystrophy.
- Molecular therapeutic strategies targeting Duchenne muscular dystrophy.
- Novel diagnostic features of dysferlinopathies.
- Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy.
- Could gene therapy be the future for Muscular dystrophy?
- Novel GNE mutations in hereditary inclusion body myopathy patients of non-Middle Eastern descent.
- Persistent expression of FLAG-tagged micro dystrophin in nonhuman primates following intraMuscular and vascular delivery.
- Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker Muscular dystrophy.
- Follistatin gene delivery enhances muscle growth and strength in nonhuman primates.
- An analysis of disease severity based on SMN2 copy number in adults with spinal Muscular atrophy.
- Utility of cystatin C to monitor renal function in Duchenne muscular dystrophy.
- Limb-girdle Muscular dystrophy type 2D gene therapy restores alpha-sarcoglycan and associated proteins.
- Spinal angiography and epidural venography in juvenile Muscular atrophy of the distal arm "Hirayama disease".
- Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.
- Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice.
- Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease.
- Partial epilepsy in an adolescent male with limb-girdle Muscular dystrophy 1B.
- Re-examination of the electrocardiogram in boys with Duchenne muscular dystrophy and correlation with its dilated cardiomyopathy.
- Fidelity of gamma-glutamyl transferase (GGT) in differentiating skeletal muscle from liver damage.
- A phase I/IItrial of MYO-029 in adult subjects with Muscular dystrophy.
- Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors.
- Gene therapy for Duchenne muscular dystrophy: expectations and challenges.
- Challenges in drug development for muscle disease: a stakeholders' meeting.
- Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis.
- The congenital Muscular dystrophies: recent advances and molecular insights.
- Limb-girdle Muscular dystrophy in the United States.
- Risks, benefits, and consent in the age of gene therapy.
- Challenges for gene therapy for Muscular dystrophy.
- Mutation rates in the dystrophin gene: a hotspot of mutation at a CpG dinucleotide.
- Gene transfer for neurologic disease: agencies, policies, and process.
- Three-tiered noninvasive diagnosis in 96% of patients with Duchenne muscular dystrophy (DMD).
- The limb girdle Muscular dystrophies: our ever-expanding knowledge.
- Rapid direct sequence analysis of the dystrophin gene.
- Clinical practice. Painful sensory Neuropathy.
- Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration.
- Dermatomyositis in two siblings and a brief review of familial dermatomyositis.
- Combined partial deficiencies of carnitine palmitoyltransferase II and mitochondrial complex I presenting as increased serum creatine kinase level.
- Fatal group a streptococcal necrotizing myopathy.
- Lambert-Eaton myasthenic syndrome in children.
- Duchenne muscular dystrophy: ethical and emotional considerations in long-term management.
- RNAi-mediated Gene Silencing of Mutant Myotilin Improves Myopathy in LGMD1A Mice.
- A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in Duchenne muscular dystrophy.
Schools
University of Texas Southwestern Medical Center At Dallas
Columbia Presby Med Center
National Institute Of Health
Ny Neur Institute
Conditions Treated
- Chronic Inflammatory Demyelinating Polyneuritis
- Diplopia
- Duchenne Muscular Dystrophy
- Gait Abnormality
- View All
Doctors Specialties
- Neurology
- Pediatric Neurology
Accepted Insurances
Awards
- America's Top Doctors
Education
-
New York Presbyterian Hospital - Columbia Campus -
University of Texas Southwestern Medical School
Hospital
-
Ohio State University Wexner Medical Center -
Nationwide Children's Hospital
Helpful Reviews
Similar Doctors
|
Dr. Poorvi P. Dalal, DO |
|
Dr. John G. Oas, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Bakri H. Elsheikh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anup D. Patel, MD |
|
|
Dr. Heather N. Flesher, MD |
|
|
Dr. Shaheryar J. Hafeez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marina Korkmazsky, DO |
|
|
Dr. Addie K. Patterson, DO |
|
|
Dr. Margie A. Ream, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles A. Sales, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Syed A. Idris, MB BS |